Cardiovascular Conditions and Treatments
Cardiovascular Conditions and Treatments is a research topic within Radiology, Nuclear Medicine and Imaging. Science Explorer counts 9.6k research works in it since 1950. 10.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis and treatment of patent ductus arteriosus (PDA) in preterm infants, with a particular emphasis on the use of indomethacin prophylaxis and ibuprofen treatment. It also explores the association between PDA and neonatal morbidity, the use of echocardiography for assessment, and the impact of ductal closure on outcomes such as bronchopulmonary dysplasia. Additionally, it examines the relationship between PDA and congenital heart disease, including cardiomyopathy.
- Patent Ductus Arteriosus
- Preterm Infants
- Echocardiography
- Indomethacin Prophylaxis
- Cardiomyopathy
- Ibuprofen Treatment
- Neonatal Morbidity
- Ductal Closure
- Congenital Heart Disease
- Bronchopulmonary Dysplasia
- Research works
- 9.6k fractional, since 1950
- In the world top 10%
- 1k per year above
- Top-10% rate
- 10.9% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +24% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cardiovascular Conditions and Treatments research?
By volume, the United States and China publish the most (396 and 94 works in 2022–2025).
By volume, 2022–2025
- 1 United States 396 works
- 2 China 94 works
- 3 Brazil 84 works
- 4 India 81 works
- 5 Japan 81 works
- 6 United Kingdom 76 works
- 7 Italy 59 works
- 8 Türkiye 50 works
- 9 South Korea 43 works
- 10 Canada 42 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cardiovascular Conditions and Treatments research?
By volume in 2022–2025, North Carolina State University publishes the most Cardiovascular Conditions and Treatments research, followed by Colorado State University and Royal Veterinary College.
By volume, 2022–2025
- 1 North Carolina State UniversityUnited States 11 works
- 2 Colorado State UniversityUnited States 10 works
- 3 Royal Veterinary CollegeUnited Kingdom 10 works
- 4 Texas A&M UniversityUnited States 10 works
- 5 University of California, DavisUnited States 9 works
- 6 Nippon Veterinary and Life Science UniversityJapan 8 works
- 7 Ghent UniversityBelgium 8 works
- 8 Utrecht UniversityNetherlands 8 works
- 9 University of FloridaUnited States 7 works
- 10 Universidade Federal do ParanáBrazil 7 works
Who are the leading researchers in Cardiovascular Conditions and Treatments?
The most-cited researchers publishing on Cardiovascular Conditions and Treatments include Masashi Yanagisawa and William C. Roberts.
- 1 Masashi Yanagisawa Japan 2.2k citations
- 2 William C. Roberts United States 2.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cardiovascular Conditions and Treatments research done?
The largest centres of Cardiovascular Conditions and Treatments research in 2022–2025 are Tokyo (Japan), London (United Kingdom), São Paulo (Brazil) and New York (United States).
Largest cities, 2022–2025
Where is the best place to study Cardiovascular Conditions and Treatments?
Among universities, judged by research, Colorado State University, Royal Veterinary College and North Carolina State University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Colorado State UniversityUnited States | 80.4 | 15.6% | 19.5× | 10 | +10.6% |
| 2 | Royal Veterinary CollegeUnited Kingdom | 77.1 | 11.3% | 155.1× | 10 | +32.8% |
| 3 | North Carolina State UniversityUnited States | 68.8 | 7.5% | 13.5× | 11 | +15.9% |
| 4 | Ghent UniversityBelgium | 55.3 | 5.8% | 10.1× | 8 | +34.2% |
| 5 | University of California, DavisUnited States | 45.9 | 12.4% | 8.1× | 9 | +52.9% |
| 6 | Texas A&M UniversityUnited States | 32.8 | 2.0% | 8.9× | 10 | +0.1% |
| 7 | Nippon Veterinary and Life Science UniversityJapan | 29.6 | 4.1% | 493.2× | 8 | -37.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cardiovascular Conditions and Treatments research growing?
Output in 2018–2022 was 24% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cardiovascular Conditions and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.